A Novel Cytidine Analog, RX-3117, Shows Potent Efficacy in Xenograft Models, even in Tumors that Are Resistant to Gemcitabine

M.Y. Yang, Y.B. Lee, C.H. Ahn, J. Kaye, T. Fine, R. Kashi, O. Ohne, K Smid, G.J. Peters, D.J. Kim

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{212774a78913434ca4669bc1a2a03b77,

title = "A Novel Cytidine Analog, RX-3117, Shows Potent Efficacy in Xenograft Models, even in Tumors that Are Resistant to Gemcitabine",

author = "M.Y. Yang and Y.B. Lee and C.H. Ahn and J. Kaye and T. Fine and R. Kashi and O. Ohne and K Smid and G.J. Peters and D.J. Kim",

year = "2014",

language = "Undefined/Unknown",

volume = "34",

pages = "6951--6959",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "12",

}

TY - JOUR

T1 - A Novel Cytidine Analog, RX-3117, Shows Potent Efficacy in Xenograft Models, even in Tumors that Are Resistant to Gemcitabine

AU - Yang, M.Y.

AU - Lee, Y.B.

AU - Ahn, C.H.

AU - Kaye, J.

AU - Fine, T.

AU - Kashi, R.

AU - Ohne, O.

AU - Smid, K

AU - Peters, G.J.

AU - Kim, D.J.

PY - 2014

Y1 - 2014

M3 - Article

SN - 0250-7005

VL - 34

SP - 6951

EP - 6959

JO - Anticancer Research

JF - Anticancer Research

IS - 12

ER -